Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death worldwide, which lacks effective inhibition of progression and metastasis in the advanced clinical stage. Mesoporous silica nanoparticle (MSN)–based cytotoxic or immunoregulatory drug–loading strategies have attracted wid...

Full description

Bibliographic Details
Main Authors: Han Wu, Xin-Fei Xu, Jia-Qi Zhu, Ming-Da Wang, Chao Li, Lei Liang, Hao Xing, Meng-Chao Wu, Feng Shen, Dong-Sheng Huang, Tian Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
mesoporous silica
hepatocellular carcinoma
immunotherapy
nanotechnology
review
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.695635/full

Internet

https://www.frontiersin.org/articles/10.3389/fbioe.2021.695635/full

Similar Items